CF advocates ratchet up pressure on Vertex, NHS officials by Eric Sagonowsky Monday, April 8, 2019 Armed with 100,000-plus signatures, cystic fibrosis patient advocates are petitioning England's parliament to force a deal for Vertex's drug Orkambi.
U.K. Supreme Court rejects Pfizer's Lyrica patent appeal by Eric Sagonowsky Wednesday, November 14, 2018 Pfizer has come up short in a long-running patent battle in the U.K. over its blockbuster Lyrica, potentially costing the drugmaker.
Officials deny shortage of Seqirus' Fluad in the U.K. by Eric Sagonowsky Wednesday, October 17, 2018 Seqirus says it is phasing delivery of its flu vaccine Fluad to the U.K. ahead of the peak season, though pharmacists have reported a lack of supply.
U.K. court invalidates Gilead's Truvada patent extension by Eric Sagonowsky Wednesday, September 19, 2018 A U.K. court nixed a patent extension for Gilead's Truvada, potentially allowing for widespread use of generics as a pre-exposure prophylaxis.
Novartis melanoma combo wins thumbs-up from NICE by Arlene Weintraub Tuesday, September 18, 2018 NICE said yes to Novartis’ Tafinlar and Mekinist in adjuvant melanoma, giving the company a head start over rival BMS.
U.K. minister accuses pharma of trying to 'rip off taxpayers' by Eric Sagonowsky Monday, September 10, 2018 Pharma may have Trump administration allies, but across the pond, Health Minister Matt Hancock has attacked, aiming his toughest remarks at Vertex.
U.K.'s top insulin provider Novo doubles stockpile for Brexit by Eric Sagonowsky Friday, September 7, 2018 In advance of Brexit next year, Novo Nordisk plans a 4-month stockpile of critical insulins. The company is the largest insulin provider in the U.K.
After snubbing Gilead, NICE gives a thumbs-up to Novartis’ CAR-T by Arlene Weintraub Wednesday, September 5, 2018 England's cost-effectiveness watchdogs gave Novartis the go-ahead for its CAR-T drug, Kymriah, to treat leukemia.
Two-thirds of U.S. teens have started HPV vaccine course: CDC by Eric Sagonowsky Tuesday, August 28, 2018 CDC officials have been pushing HPV vaccination, and in 2017—just as in the previous four years—those efforts yielded only a slight increase.
U.K. tells drugmakers to stockpile in case Brexit goes bad by Eric Palmer Thursday, August 23, 2018 England's NHS is mandating that all drugmakers stockpile an extra six weeks' worth of drugs in the country in case Brexit goes badly.
